Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Compugen Ltd (CGEN)

17.2   -0.35 (-1.99%) 08-14 16:00
Open: 17.69 Pre. Close: 17.55
High: 17.75 Low: 16.8638
Volume: 1,357,597 Market Cap: 1,433M
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets, including T cell immune checkpoints and other early-stage immuno-oncology programs focusing on myeloid target. Its product pipeline consists of COM701, a therapeutic antibody that is in phase I clinical trials for PVRIG; BAY 1905254, a therapeutic antibody that is in phase I clinical trials for ILDR2; and COM902, a therapeutic immuno-oncology antibody for TIGIT program. Compugen Ltd.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.771 - 17.882 17.882 - 17.961
Low: 16.603 - 16.738 16.738 - 16.834
Close: 17.021 - 17.221 17.221 - 17.362

Technical analysis

as of: 2020-08-14 4:28:22 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 21.05     One year: 24.58
Support: Support1: 15.42    Support2: 13.81
Resistance: Resistance1: 18.02    Resistance2: 21.05
Pivot: 15.96
Moving Average: MA(5): 16.99     MA(20): 15.81
MA(100): 13.89     MA(250): 9.14
MACD: MACD(12,26): 0.55     Signal(9): 0.35
Stochastic oscillator: %K(14,3): 87.40     %D(3): 84.85
RSI: RSI(14): 59.74
52-week: High: 18.02  Low: 3.64  Change(%): 342.2
Average Vol(K): 3-Month: 138638  10-Days: 155182

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CGEN has closed below upper band by 20.5%. Bollinger Bands are 5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 14 Aug 2020
Compugen Ltd. (CGEN) Volatility Hits 5.64% – Here’s What A Good Investor Should Do - Stocks Register

Thu, 13 Aug 2020
Compugen Ltd. (NASDAQ:CGEN) up 10.66% over the past 30 days: Any Troubles Ahead? - Marketing Sentinel

Fri, 07 Aug 2020
Compugen Ltd. (NASDAQ:CGEN) is Holding Steady - The Oracle Dispatch

Tue, 04 Aug 2020
An in-depth look at the Compugen Ltd. (CGEN) stock - Marketing Sentinel

Fri, 31 Jul 2020
Compugen Ltd (CGEN) CEO Anat Dayag on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Fri, 31 Jul 2020
Compugen Ltd. (CGEN) Q2 2020 Earnings Call Transcript - Motley Fool

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 79
Shares Float (M) 70
% Held by Insiders 0.18
% Held by Institutions 31.24
Shares Short (K) 6,420
Shares Short P. Month (K) 4,420

Stock Financials

EPS -0.390
EPS Est This Year -0.730
EPS Est Next Year -0.830
Book Value (p.s.) 1.620
Profit Margin
Operating Margin
Return on Assets (ttm) -19.1
Return on Equity (ttm) -35.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.339
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -44.10
PEG Ratio
Price to Book value 10.62
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.